Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Secukinumab”

191 trials

Showing 20 of 191 results

Large-scale testing (Phase 3)Study completedNCT03478787
What this trial is testing

Risankizumab Versus Secukinumab for Participants With Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
AbbVie 327
Large-scale testing (Phase 3)Study completedNCT02662985
What this trial is testing

Study of Power Doppler Ultrasound (PDUS) to Measure Response of Secukinumab Treatment in Patients With Active Psoriatic Arthritis (PsA)

Who this might be right for
Psoriatic Arthritis
Novartis Pharmaceuticals 166
Testing effectiveness (Phase 2)Study completedNCT04403243
What this trial is testing

COLchicine Versus Ruxolitinib and Secukinumab in Open-label Prospective Randomized Trial in Patients With COVID-19

Who this might be right for
COVID 19
Lomonosov Moscow State University Medical Research and Educational Center 70
Not applicableEnded earlyNCT06715254
What this trial is testing

A Real-world Study of Tuberculosis Incidence in AS, PsA, or PsO Patients Treated With Secukinumab in Brazil

Who this might be right for
Tuberculosis
Novartis Pharmaceuticals 152
Large-scale testing (Phase 3)Study completedNCT04711902
What this trial is testing

Study of Efficacy and Safety of Secukinumab in Chinese Subjects With Active PsA Compared to Placebo.

Who this might be right for
Psoriatic Arthritis
Novartis Pharmaceuticals 41
Large-scale testing (Phase 3)Study completedNCT02696031
What this trial is testing

Study of Efficacy and Safety of Secukinumab in Patients With Non-radiographic Axial Spondyloarthritis

Who this might be right for
Non-radiographic Spondyloarthritis
Novartis Pharmaceuticals 555
Testing effectiveness (Phase 2)Study completedNCT03131570
What this trial is testing

Safety and Efficacy of Secukinumab in Mild Psoriasis

Who this might be right for
Psoriasis
James G. Krueger, MD, PhD 23
Post-approval studies (Phase 4)Study completedNCT04717466
What this trial is testing

Brain Changes in Psoriasis After Secukinumab Treatment

Who this might be right for
PsoriasisHealthy
University of Miami 20
Large-scale testing (Phase 3)Study completedNCT02721966
What this trial is testing

Study of the Efficacy and Safety of Secukinumab in Participants With Active Psoriatic Arthritis With Axial Skeleton Involvement

Who this might be right for
Axial Psoratic Arthritis
Novartis Pharmaceuticals 503
Testing effectiveness (Phase 2)Study completedNCT03079531
What this trial is testing

Open Label Study to Assess the Effect of Secukinumab in Moderate to Severe Papulopustular Rosacea

Who this might be right for
Papulopustular Rosacea
Anne Chang 24
Large-scale testing (Phase 3)Ended earlyNCT05722522
What this trial is testing

Study of Efficacy and Safety of Secukinumab in Participants With Moderate-severe Rotator Cuff Tendinopathy

Who this might be right for
Rotator Cuff Tendinopathy
Novartis Pharmaceuticals 33
Post-approval studies (Phase 4)UnknownNCT04469829
What this trial is testing

Methotrexate Versus Secukinumab Safety in Psoriasis Patients With Metabolic Syndrome

Who this might be right for
PsoriasisMetabolic Syndrome
Universita di Verona 70
Large-scale testing (Phase 3)Study completedNCT02750592
What this trial is testing

Study of Efficacy and Safety of Secukinumab in Japanese Patients With Active Ankylosing Spondylitis

Who this might be right for
Ankylosing Spondylitis
Novartis Pharmaceuticals 30
Testing effectiveness (Phase 2)Study completedNCT01359943
What this trial is testing

Efficacy, Safety and Tolerability of Secukinumab in Patients With Rheumatoid Arthritis Taking Methotrexate

Who this might be right for
Rheumatoid Arthritis
Novartis Pharmaceuticals 221
Testing effectiveness (Phase 2)Study completedNCT02594098
What this trial is testing

Secukinumab for Treatment of Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Icahn School of Medicine at Mount Sinai 41
Not applicableStudy completedNCT07130331
What this trial is testing

Efficacy and Influencing Factors of Secukinumab in Patients With Axial Spondyloarthritis

Who this might be right for
Axial Spondylarthritis (axSpA)Secukinumab
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 200
Large-scale testing (Phase 3)Study completedNCT02474069
What this trial is testing

Secukinumab Dosage Optimisation in Partial Responders With Moderate to Severe Plaque-type Psoriasis

Who this might be right for
Moderate to Severe Plaque-type Psoriasis
Novartis Pharmaceuticals 772
Not applicableStudy completedNCT05215561
What this trial is testing

Special Drug Use-results Survey to Evaluate Safety and Efficacy of Cosentyx in Pediatric Patients With PsV, PsA, or GPP

Who this might be right for
Psoriasis VulgarisPsoriatic ArthritisPustular Psoriasis
Novartis Pharmaceuticals 36
Not applicableStudy completedNCT04894890
What this trial is testing

A Prospective Multicenter Study for the Assessment of Treatment Patterns, Effectiveness and Safety of Secukinumab in Adult Patients With Moderate to Severe Plaque Psoriasis in a Real-world Setting in China

Who this might be right for
Psoriasis
Novartis Pharmaceuticals 1,002
Not applicableStudy completedNCT05388916
What this trial is testing

A Real-world Study to Assess Safety and Effectiveness of Secukinumab in Pediatric Plaque Psoriasis Patients in China

Who this might be right for
Moderate to Severe Chronic Plaque Psoriasis
Novartis Pharmaceuticals 42
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation